FSN Capital’s Acquisition of Majority Stake in Epista Life Science

Plesner advised FSN Capital on the deal. The leading Nordic private equity firm, FSN Capital, has signed an agreement to acquire a majority stake in Epista…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now